Table 1 Patient characteristics
From: Ramelteon combined with an α1-blocker decreases nocturia in men with benign prostatic hyperplasia
Variables | Number (%) or Median (mean±SD) |
|---|---|
No. of patients | 19 |
Age, years | 72.0 (72.1 ± 10.6) |
Prostate vol, mL | 37.3 (41.9 ± 25.3) |
Serum PSA, ng/mL | 3.6 (4.7 ± 4.1) |
Uroflowmetry | |
Peak flow rate, mL/s | 10.5 (13.2 ± 10.0) |
Average flow rate, mL/s | 5.0 (7.1 ± 5.5) |
Residual volume, mL | 20.0 (20 ± 21.8) |
Type of alpha-1-adrenergic antagonists (blockers) | |
Tamsulosin (0.2 mg/day) | 8 (42.1%) |
Silodosin (8 mg/day) | 2 (10.5%) |
Naftopidil (75 mg/day) | 9 (47.4%) |